Guardant Health (GH) director sells 1,951 shares in open-market trade

Rhea-AI Filing Summary

Guardant Health director Tariq Musa sold 1,951 shares of Common Stock in an open-market transaction. The shares were sold at an average price of $131.16 per share. After this sale, Musa directly holds 11,048 Guardant Health shares, indicating he retains a significant ongoing equity position in the company.

Insider Trade Summary 10b5-1

Net Seller: 1,951 shares ($255,893)

Net Sell 1 txn

Insider Tariq Musa

Role null

Sold 1,951 shs ($256K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,951	$131.16	$256K

Holdings After Transaction: Common Stock — 11,048 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 1,951 shares Sale price per share: $131.16 per share Shares held after transaction: 11,048 shares +1 more

4 metrics

Shares sold 1,951 shares Open-market sale on June 22, 2026

Sale price per share $131.16 per share Average sale price for Common Stock

Shares held after transaction 11,048 shares Direct ownership following sale

Net buy/sell shares -1,951 shares Net-sell direction from transaction summary

Key Terms

open-market sale, Common Stock, Form 4, net-sell

4 terms

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

net-sell financial

"netBuySellDirection: "net-sell""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/23/2026 - 05:29 PM Accepted by SEC EDGAR 06/23/2026 - 05:29 PM Learn about SEC filing dates

FAQ

What insider transaction did Guardant Health (GH) director Tariq Musa report?

Director Tariq Musa reported an open-market sale of 1,951 Guardant Health shares. The transaction involved Common Stock and reflects a discretionary sale, as disclosed in a Form 4 insider filing submitted to the SEC for regulatory transparency and investor awareness.

At what price did Tariq Musa sell Guardant Health (GH) shares?

Tariq Musa sold 1,951 Guardant Health shares at an average price of $131.16 per share. This price represents the reported transaction value for the open-market sale disclosed, providing investors a clear view of the level at which the director sold shares.

How many Guardant Health (GH) shares does Tariq Musa hold after the sale?

Following the reported sale, Tariq Musa directly holds 11,048 Guardant Health shares. This post-transaction holding shows that, despite the sale, he continues to maintain a meaningful ownership stake in the company’s Common Stock, as reflected in the Form 4 filing.

When did Tariq Musa’s Guardant Health (GH) share sale take place?

The Form 4 indicates Tariq Musa’s sale of Guardant Health Common Stock occurred on June 22, 2026. This transaction date helps investors align the insider activity with broader market conditions and any company-specific developments around that time.

Was Tariq Musa’s Guardant Health (GH) transaction an open-market sale?

Yes. The Form 4 describes the transaction as an open-market sale of Common Stock. This means the shares were sold through the public market rather than via a private arrangement, using the ticker GH on the relevant trading venue.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tariq Musa

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/22/2026		S		1,951	D	$131.16	11,048	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Musa Tariq	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)